Firefly Neuroscience, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +164.4% | +42.5% | -12.1% | +60.5% | -13.4% | +168.7% | +20.8% | -16.9% | -15.6% | +4.1% | +53.7% | |
| – | +138.1% | -33.4% | -22.2% | +128.0% | -1.4% | +294.9% | -27.4% | -27.9% | -25.8% | +10.8% | +129.2% | |
| – | +140.0% | -73.7% | -56.7% | +403.8% | +47.2% | +427.3% | -38.0% | -26.9% | -36.5% | +13.8% | +195.0% | |
| – | +140.0% | -73.7% | -56.7% | +403.8% | +47.2% | +427.3% | -38.0% | -26.9% | -36.5% | +13.8% | +195.0% | |
| – | +100.0% | +823.8% | +2.0% | -89.1% | +40.7% | -17.4% | +97.0% | -6.6% | +5.4% | -0.5% | -2.6% | |
| – | – | – | – | – | – | – | – | -39.8% | +35.0% | -4.6% | -57.3% | |
| – | – | – | +0.0% | – | – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | – | +149.1% | -3.5% | +19.6% | -83.8% | -5.6% | +545.3% | -18.1% | -4.1% | -4.4% | -4.5% | |
| – | +32.4% | -18.8% | -6.1% | +31.3% | +96.3% | +44.3% | -60.5% | -3.1% | +3.3% | -13.1% | -14.7% | |
| – | +32.4% | -19.4% | -6.1% | +32.4% | +96.3% | +44.3% | -61.1% | -2.7% | +3.7% | -12.9% | -14.5% | |
| – | – | – | -41.3% | – | – | – | – | – | – | – | – | |
| – | +45.8% | +5.1% | +14.6% | +82.0% | +31.4% | -11.2% | -6.8% | -10.5% | +0.1% | -1.3% | -33.7% | |
| – | – | +1,467.4% | -19.3% | +101.3% | -113.5% | – | +133.4% | -20.2% | -20.9% | +10.5% | +73.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | -10.0% | +18.2% | +19.0% | +27.2% | +6.5% | +0.0% | +20.2% | +26.8% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.